Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | Long-term effectiveness of levodopa-carbidopa intestinal gel in Parkinson’s disease

Angelo Antonini • 20 May 2020
EAN 2020
Movement Disorders Parkinson's Disease Carbidopa Levodopa

Angelo Antonini, MD, PhD, University of Padua, Padua, Italy, discusses the long-term effectiveness of levodopa-carbidopa intestinal gel on motor and non-motor symptoms in advanced Parkinson’s disease (PD) on the Italian GLORIA patient population. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Angelo Antonini

1:50
Clinical highlights in Parkinson's disease
Angelo Antonini • 27 Aug 2023
1:29
Benefits and challenges associated with subcutaneous infusions for Parkinson’s disease
Angelo Antonini • 27 Aug 2023
1:11
Wearables: technological advancements in movement disorder management
Angelo Antonini • 1 Jul 2023
1:36
Parkinson's disease: updates in the disease-modifying space
Angelo Antonini • 1 Jul 2023

Related Videos

1:58
Ambroxol & other targeted therapies in Parkinson's
K Ray Chaudhuri • 21 Mar 2024
3:00
The use of precision medicine in Parkinson’s disease
K Ray Chaudhuri • 21 Mar 2024
3:19
An update on the dashboard of vitals in Parkinson's: working towards global implementation
K Ray Chaudhuri • 21 Mar 2024
2:09
Parkinson's beyond dopamine: the role of acetylcholine, noradrenaline, and serotonin
K Ray Chaudhuri • 21 Mar 2024
The content of VJNeurology is intended for healthcare professionals